Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis
NUDGE
2 other identifiers
interventional
30
1 country
1
Brief Summary
The goal of this clinical trial is to help adolescents and young adults between the ages of 13-25 with Cystic Fibrosis (CF), medically stable, able to speak and read English, and are not experiencing a CF - related exacerbation, who are already active to remain, or gradually encourage them to increase their levels of physical activity Participants will be asked to utilize a smartphone program, called NUDGE that we have developed. NUDGE is a chatbot with evidence-based features known to help teens make progress toward health goal:
- Set and review goals
- Self-monitor progress
- Provide feedback on goal attainment
- Revise future goals
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2024
CompletedFirst Posted
Study publicly available on registry
September 27, 2024
CompletedStudy Start
First participant enrolled
February 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
March 13, 2026
February 1, 2026
1.4 years
September 20, 2024
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Recruitment
Recruitment: Our recruitment goal is 30 AYAs with CF.
Baseline
Retention
Retention: Our criterion for success is no more than 20% attrition.
3-month
Engagement
Engagement: We will be considered engagement a success if AYAs in NUDGE respond to an average of 4/7 (57%) messages each week during the first 3 months that a participant uses NUDGE.
3-month
Acceptability
Acceptability: We will consider NUDGE acceptable if users report a satisfaction rating of ≥3 (mostly satisfied) on our modified Client Satisfaction Questionnaire and rate it as usable as ≥70% of other computerized systems on the System Usability Scale. We will also be attentive to themes in relation to the barriers and facilitators of using NUDGE and its success in promoting PA in interviews.
3-month
Secondary Outcomes (3)
Actigraphy
Baseline, 3-month, and 6-month
Lung Functioning
Baseline, 3-month, and 6-month
CF Quality of Life
Baseline, 3-month, and 6-month
Study Arms (2)
NUDGE
EXPERIMENTALEducation
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- years old
- Has a verified CF diagnosis or CF-related disorder
- Medically stable (i.e., FEV1\>30%, not experiencing a CF-related exacerbation)
- Speaks and reads English
You may not qualify if:
- Have a comorbidity limiting PA participation (e.g., neurological condition)
- Have a significant cognitive impairment that interferes with study completion
- Have any oxygen, CPAP or BiPAP requirement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nemours Children's Cliniclead
- Cystic Fibrosis Foundationcollaborator
Study Sites (1)
Nemours Childrens Health
Jacksonville, Florida, 32207, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Research Scientist
Study Record Dates
First Submitted
September 20, 2024
First Posted
September 27, 2024
Study Start
February 18, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
March 13, 2026
Record last verified: 2026-02